SEOUL -- South Korean lawmakers are calling on financial regulators to broaden the investigation of accounting fraud at Samsung BioLogics to encompass its parent Samsung C&T, the group's de facto holding company, threatening the succession process put in place by the controlling family.
Companies
Lawmakers want probe of Samsung parent in biotech fraud
Investigation into C&T risks upsetting Lee Jae-yong succession at conglomerate
Samsung group vice chairman Lee Jae-yong, left, visits Mangyongdae Children's Palace in Pyongyang, North Koreain September. Lawmakers have accused Samsung of using BioLogics to smooth Lee's succession.
Read Next
Latest on Companies
